Comparative efficacy and safety of GLP-1 receptor agonists for weight reduction: A model-based meta-analysis of placebo-controlled trials

Authors:

Top Cited Papers
Open Access
Abstract
No abstract available
Funding Information
  • National Key Research and Development Program of China (2022YFC3502000)
  • National Natural Science Foundation of China (82174229)

This publication has 33 references indexed in Scilit: